Our preclinical drug product development services cover a range of critical stages, beginning with drug substance characterization, salt, and polymorph screening, and extending to formulation development for preclinical toxicology studies. With expertise in drug substance characterization, salt, and polymorph screening, as well as preclinical toxicology formulation development, especially for poorly soluble and permeable drug substances, we ensure meticulous execution to uphold top standards of innovation, quality and safety. Through our comprehensive services in these areas, we aim to assist our clients in moving their drug candidates through the preclinical development phase efficiently and successfully.
